A fully funded PhD position at the University of Bristol, funded by the Wallscourt Foundation, a charitable organisation with historic links to UWE Bristol, as part of a wider project on long-term health conditions.
Globally, colorectal cancer results in over 900,000 fatalities annually. It is anticipated that the incidence will increase by an additional 50% by 2040, with younger individuals increasingly experiencing the condition. It can take decades for these tumors to progress from polyps, which are benign tumors found in 40% of adults over 50, to cancer, making this a chronic condition that frequently stays undiagnosed until it is too late. It is unknown why certain tumors develop while others do not, but it is believed that their microenvironment—which includes their nutrition and gut microbiota determines this. Our newly published research demonstrates that whereas gut microorganisms can induce tumor-promoting effects in both malignant and benign tumor cells, their interactions with them are distinct.
Eligibility
Applicants must have at least a 2:1 or equivalent degree in Biomedical Science, Molecular or Biological Science or a related discipline and ideally will have or be working towards a postgraduate, research-based qualification (or equivalent experience).
Experience in techniques involving mammalian cell culture, microbiology, molecular biology and/or metabolomics would be an advantage.
International students are required to have IELTS 7.0 or above.
Funding Details
The studentship comes with a tax-exempt stipend (currently £15,009 annually) and is available for three years starting on April 1, 2024. Additionally, candidates from abroad and those from home will get full-time tuition reimbursement for a maximum of three years.
Deadline
The last date for applying is 17th January 2024.
Application
Last Update
